[Epidermolysis bullosa acquisita. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie]

Ann Dermatol Venereol. 2011 Mar;138(3):274-9. doi: 10.1016/j.annder.2011.01.013. Epub 2011 Feb 18.
[Article in French]
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use
  • Biopsy
  • Colchicine / administration & dosage
  • Colchicine / therapeutic use
  • Comorbidity
  • Dapsone / administration & dosage
  • Dapsone / therapeutic use
  • Epidermolysis Bullosa Acquisita / diagnosis*
  • Epidermolysis Bullosa Acquisita / drug therapy*
  • Epidermolysis Bullosa Acquisita / epidemiology
  • Epidermolysis Bullosa Acquisita / pathology
  • Epidermolysis Bullosa Acquisita / therapy
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunologic Tests / methods
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use
  • Immunotherapy
  • Patient Care Team
  • Patient Education as Topic
  • Photochemotherapy
  • Physical Examination
  • Risk Factors
  • Rituximab

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Murine-Derived
  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Rituximab
  • Dapsone
  • Colchicine